1. M. Rowland. Intra-individual variability in pharmacokinetics. In: D. D. Breimer (ed.),Towards Better Safety of Drugs and Pharmaceutical Products, Elsevier, North-Holland, 1980.
2. A. Grahnen. The impact of time-dependent phenomena on bioequivalence studies. In: D. D. Breimer and P. Speiser (eds.),Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1985.
3. S. L. Beal and L. B. Sheiner.NONMEM Users Guides, NONMEM Project Group UCSF, San Francisco, CA, 1992.
4. M. Davidian and A. R. Gallant. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine.J. Pharmacokin. Biopharm. 20:531–558 (1992).
5. A. Mallet. A maximum likelihood estimation method for random coefficient regression models.Biometrika 73:645–656 (1986).